|
|
|
Volumn 4, Issue 11 Suppl 22, 2006, Pages
|
|
Chronic lymphocytic leukemia: current and emerging treatment approaches.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALEMTUZUMAB;
ANTINEOPLASTIC AGENT;
CANCER ANTIBODY;
CHLORAMBUCIL;
CYCLOPHOSPHAMIDE;
DRUG DERIVATIVE;
FLUDARABINE;
IMMUNOGLOBULIN HEAVY CHAIN;
MONOCLONAL ANTIBODY;
PROTEIN KINASE ZAP 70;
VIDARABINE;
ZAP70 PROTEIN, HUMAN;
B CELL LEUKEMIA;
BIOSYNTHESIS;
CHROMOSOME 12;
DISEASE FREE SURVIVAL;
DRUG EFFECT;
DRUG SCREENING;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
IMMUNOGLOBULIN VARIABLE REGION;
METABOLISM;
MINIMAL RESIDUAL DISEASE;
MORTALITY;
POLYMERASE CHAIN REACTION;
REVIEW;
RISK FACTOR;
SURVIVAL RATE;
TRISOMY;
ANTIBODIES, MONOCLONAL;
ANTIBODIES, NEOPLASM;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CHLORAMBUCIL;
CHROMOSOMES, HUMAN, PAIR 12;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DRUG SCREENING ASSAYS, ANTITUMOR;
FLOW CYTOMETRY;
GENE EXPRESSION REGULATION, LEUKEMIC;
HUMANS;
IMMUNOGLOBULIN HEAVY CHAINS;
IMMUNOGLOBULIN VARIABLE REGION;
LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;
NEOPLASM, RESIDUAL;
POLYMERASE CHAIN REACTION;
RISK FACTORS;
SURVIVAL RATE;
TRISOMY;
VIDARABINE;
ZAP-70 PROTEIN-TYROSINE KINASE;
|
|
EID: 35348996680
PISSN: 15430790
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (19)
|
|
References (0)
|
